» Articles » PMID: 37672362

The Application of CT Radiomics in the Diagnosis of Vein Wall Invasion in Patients With Renal Cell Carcinoma Combined With Tumor Thrombus

Overview
Journal Oncologist
Specialty Oncology
Date 2023 Sep 6
PMID 37672362
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The objective of this study was to explore the application of radiomics combined with machine learning to establish different models to assist in the diagnosis of venous wall invasion in patients with renal cell carcinoma and venous tumor thrombus and to evaluate the diagnostic efficacy.

Materials And Methods: We retrospectively reviewed the data of 169 patients in Peking University Third Hospital from March 2015 to January 21, who was diagnosed as renal mass with venous invasion. According to the intraoperative findings, 111 patients were classified to the venous wall invasion group and 58 cases in the non-invasion group. ITK-snap was used for tumor segmentation and PyRadiomics 3.0.1 package was used for feature extraction. A total of 1598 features could be extracted from each CT image. The patients were divided into training set and testing set by time. The elastic-net regression with 4-fold cross-validation was used as a dimension-reduction method. After feature selection, a support vector machines (SVM) model, a logistic regression (LR) model, and an extra trees (ET) model were established. Then the sensitivity, specificity, accuracy, and the area under the curve (AUC) were calculated to evaluate the diagnostic performance of each model on the testing set.

Results: Patients before September 2019 were divided into the training set, of which 88 patients were in the invasion group and 42 patients were in the non-invasion group. The others were in the testing set, of which 32 patients were in the invasion group and 16 patients were in the non-invasion group. A total of 34 radiomics features were obtained by the elastic-net regression. The SVM model had an AUC value of 0.641 (95% CI, 0.463-0.769), a sensitivity of 1.000, and a specificity of 0.062. The LR model had an AUC value of 0.769 (95% CI, 0.620-0.877), a sensitivity of 0.913, and a specificity of 0.312. The ET model had an AUC value of 0.853 (95% CI, 0.734-0.948), a sensitivity of 0.783, and a specificity of 0.812. Among the 3 models, the ET model had the best diagnostic effect, with a good balance of sensitivity and specificity. And the higher the tumor thrombus grade, the better the diagnostic efficacy of the ET model. In inferior vena cava tumor thrombus, the sensitivity, specificity, accuracy, and AUC of ET model can be improved to 0.889, 0.800, 0.857, 0.878 (95% CI, 0.745-1.000).

Conclusion: Machine learning combined with radiomics method can effectively identify whether venous wall was invaded by tumor thrombus and has high diagnostic efficacy with an AUC of 0.853 (95% CI, 0.734-0.948).

Citing Articles

CT-based multi-regional radiomics model for predicting contrast medium extravasation in patients with tumors: A case-control study.

Hu L, Zhang J, Wu X, Xu W, Wang Z, Zhang H PLoS One. 2025; 20(3):e0314601.

PMID: 40063894 PMC: 11893132. DOI: 10.1371/journal.pone.0314601.


Navigating advanced renal cell carcinoma in the era of artificial intelligence.

Najem E, Shaikh M, Shinagare A, Krajewski K Cancer Imaging. 2025; 25(1):16.

PMID: 39966980 PMC: 11837394. DOI: 10.1186/s40644-025-00835-7.


Development and validation of a radiomics-based nomogram for predicting pathological grade of upper urinary tract urothelial carcinoma.

Zheng Y, Shi H, Fu S, Wang H, Li X, Li Z BMC Cancer. 2024; 24(1):1546.

PMID: 39696125 PMC: 11657141. DOI: 10.1186/s12885-024-13325-z.


Radiomics for differential diagnosis of Bosniak II-IV renal masses via CT imaging.

Zhao X, Yan Y, Xie W, Qin Z, Zhao L, Liu C BMC Cancer. 2024; 24(1):1508.

PMID: 39643905 PMC: 11622457. DOI: 10.1186/s12885-024-13283-6.


CT-based radiomics: predicting early outcomes after percutaneous transluminal renal angioplasty in patients with severe atherosclerotic renal artery stenosis.

Fu J, Fang M, Lin Z, Qiu J, Yang M, Tian J Vis Comput Ind Biomed Art. 2024; 7(1):1.

PMID: 38212451 PMC: 10784441. DOI: 10.1186/s42492-023-00152-5.


References
1.
Blute M, Leibovich B, Lohse C, Cheville J, Zincke H . The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004; 94(1):33-41. DOI: 10.1111/j.1464-410X.2004.04897.x. View

2.
Gu L, Li H, Wang Z, Wang B, Huang Q, Lyu X . A systematic review and meta-analysis of clinicopathologic factors linked to oncologic outcomes for renal cell carcinoma with tumor thrombus treated by radical nephrectomy with thrombectomy. Cancer Treat Rev. 2018; 69:112-120. DOI: 10.1016/j.ctrv.2018.06.014. View

3.
Wang B, Li Y, Fang Y, Zhang S, Ma L . Imaging predictors for assessment of inferior vena cava wall invasion in patients with renal cell carcinoma and inferior vena cava tumor thrombus: a retrospective study. Chin Med J (Engl). 2020; 133(17):2078-2083. PMC: 7478742. DOI: 10.1097/CM9.0000000000000828. View

4.
Overholser S, Raheem O, Zapata D, Kaushik D, Rodriguez R, Derweesh I . Radiologic indicators prior to renal cell cancer thrombectomy: Implications for vascular reconstruction and mortality. Urol Ann. 2016; 8(3):312-6. PMC: 4944624. DOI: 10.4103/0974-7796.184888. View

5.
Gao J, Ye F, Han F, Jiang H, Zhang J . A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma. Front Immunol. 2022; 13:956679. PMC: 9513051. DOI: 10.3389/fimmu.2022.956679. View